Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Expands Indian Research Facility, Making it Company's Largest Worldwide


Agilent Technologies said this week that it has expanded its Life Sciences and Chemical Analysis Center of Excellence in Bangalore.

The center, which at 8,000 square feet is the company's largest research facility worldwide, now offers access to a number of its high-end products, including instruments like the 6490 triple-quadrupole and 6540 Q-TOF mass spectrometers and 1290 and 1260 Infinity LCs that are commonly used in proteomics research.

The company's core instruments are also on offer at the facility, including its range of liquid chromatographs and mass spectrometers. Customers can use the center to test the performance of Agilent products for their samples and applications.

In addition to the expansion of the center, Agilent has opened a life science application development lab, which it said in a statement is designed to "accelerate the discovery of life science analysis workflows."

"India continues to be one of the most important markets for Agilent globally, with a significant presence of high-end R&D in pharmaceuticals and biotechnology," country general manager for India, Parmeet Ahuja, said in a statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.